Author:
Nau Françoise,Guérin-Dubiard Catherine,Croguennec Marc
Publisher
Springer Berlin Heidelberg
Reference27 articles.
1. Aktas Y, Yemisci M, Andrieux K, Gursoy RN, Alonso MJ, Fernandez-Megia E, Novoa-Carballal R, Quinoa E, Riguera R, Sargon MF, Celik HH, Demir AS, Hincal AA, Dalkara T, Capan Y, Couvreur P (2005) Development and brain delivery of chitosan–PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjug Chem 16:1503–1511.
2. Alon R, Bayer EA, Wilchek M (1990) Streptavidin contains an RYD sequence which mimics the RGD receptor domain of fibronectin. Biochem. Biophys. Res Commun 170:1236–1241.
3. Barry MA, Campos SK, Ghosh D, Adams KE, Mok H, Mercier GT, Parrott MB (2003) Biotinylated gene therapy vectors. Expert Opin Biol Ther 3:925–940.
4. Bayer EA, Wilchek M (1994) Modified avidins for application in avidin–biotin technology: an improvement on nature. In: Sim JS, Nakai S (eds) Egg uses and processing technologies, new developments, CABI-UK, pp 158–177.
5. Bayer EA, Wilchek M, Skutelsky E (1976) Affinity cytochemistry: the localization of lectin and antibody receptors on erythrocytes via the avidin–biotin complex. FEBS Lett 68:240–244.